Skip to main content
Premium Trial:

Request an Annual Quote

Hogan Steps Down as GE Healthcare Chief, Fletcher Joins PerkinElmer's LAS Unit, Blitzer Appointed Director at Znomics

NEW YORK (GenomeWeb News) – GE Healthcare CEO Joseph Hogan has left the company to take a position as CEO of the power and automation company ABB. GE has named John Dineen, who until now was CEO of GE Transportation, to fill Hogan’s spot.
 

 
Alan Fletcher has joined PerkinElmer as vice president of business development for the company’s Life and Analytical Sciences business. Fletcher most recently held multiple positions at GE Healthcare and before that he was involved in biotechnology, R&D, and technology transfer for other Fortune 500 companies. He has a doctorate in biochemical pharmacology from the University of London.
 

 
Predictive Biosciences has named Vikram Lamba to be chief financial officer, and it has appointed Ellen Sheets to be chief medical officer.
 
Sheets recently was CMO and senior VP at Hologic, where she also served as general manager of the company’s breast health unit, and also was VP of clinical affairs. Lamba previously was VP of corporate development at Advanced Medical Optics, and before that was CFO of GeneOhm Sciences.
 

 
Znomics has appointed Charles Blitzer to the company’s board of directors. Blitzer has more than 30 years of experience in executive leadership positions in the pharmaceutical industry. He has worked at Barbeau Pharma, Fulcrum Pharma, MGI Pharma, and at Marion Merrill Dow.
 

 
William Sullivan has taken on the role of senior VP of diagnostic operations at HistoRx. In the newly created job, Sullivan will be responsible for expanding the company’s diagnostics development and manufacturing. Sullivan was VP of corporate development for Vermillion (previously Ciphergen), and he was VP of operations at Nichols Institute Diagnostics.
 

 
Jeffrey Vick has resigned as group CEO at Silence Therapeutics for personal reasons, the company said this week. The company’s board of directors has appointed Iain Ross, who currently is non-executive chairman, to be full time chairman and group CEO immediately. Jeremy Curnock Cook, a non-executive director, has been appointed senior independent non-executive director.
 

 
Wisconsin Governor Jim Doyle has named Third Wave Technologies co-founder and University of Wisconsin professor James Dahlberg to be his science adviser, a newly created and unpaid position. Dahlberg has been at the university since 1969.
 

 
Third Wave is undergoing some executive shuffling of its board of directors as part of its merger agreement with Hologic.
 
Katherine Napier, Gordon Brunner, and David Thompson have resigned from Third Wave’s board. Glenn Muir, Robert Cascella, Mark Casey, Stuart Kingsley, and Howard Doran have been named director designees, but the company said it does not expect to name any of the director designees to any committee of the board at the present time.
 

 
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.